Development of a Computerized Neurocognitive Remediation Package And Phase II Trial For Assessment Of Its Efficacy In Cognitive Function Among Patients With Schizophrenia

All India Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Male or female between 18-45 years of age
•Meeting the DSM-5 clinical criteria for schizophrenia (APA, 2013)
•Patients currently stabilized on same antipsychotics for a period of at least 6 weeks
•Patients or primary caregiver with capacity and willingness to give informed consent.
•Both in-patients and out-patients
•Having basic familiarity & comfort with using computers
•Both Right and Left Handed
•Education up to Primary level

•Presence of past or current co-morbid Axis I disorders including substance abuse/dependence (other than caffeine or nicotine)
•Any history of seizure EXCEPT those therapeutically induced by ECT
•History suggestive of any neurological or progressive neurological condition.
•Having Colour blindness or Blindness
•Hearing impairment
•Non-consenting individuals
•Visual or motor disability which may hinder use of computers.

发起方